Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Morphoea
ADR ID BADD_A02851
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.07      Scleroderma and associated disorders
10.04.07.002      Morphoea
15      Musculoskeletal and connective tissue disorders
15.06      Connective tissue disorders (excl congenital)
15.06.01      Connective tissue disorders NEC
15.06.01.008      Morphoea
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.02      Connective tissue disorders
23.03.02.011      Morphoea
Description A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules. [MeSH]
MedDRA Code 10027982
MeSH ID D012594
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Circumscribed scleroderma | En coup de sabre | Generalised morphoea | Linear morphoea | Linear scleroderma | Morphea | Morphea guttate | Morphoea | Scleroderma circumscribed | Skin sclerosis finger and palm | White spot disease | Morphoea guttate | Generalized morphea | Linear morphea | Scleroderma, Localized | Localized Scleroderma | Sclerodermas, Localized | Scleroderma, Circumscribed | Circumscribed Scleroderma | Dermatosclerosis | Morpheas | Scleroderma, Linear | Linear Scleroderma | Frontal Linear Scleroderma en Coup de Sabre
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.000820%
BADD_D00349Capecitabine0.000168%
BADD_D01653Paclitaxel--
BADD_D01720Pentazocine lactate--
BADD_D01909Ramipril0.000186%
BADD_D02262Tranylcypromine--
The 1th Page    1    Total 1 Pages